Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
Globe Newswire•21/09/2026•09:00 ET
0
Denver, CO, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation prodrugs for patients living with inflammatory and fibrotic diseases, today announced that JD Finley, Chief Executive Officer, and Mitchell Jones, M.D., Ph.D., President and Chief Medical Officer, will participate in the Stifel 2026 Virtual Immunology and Inflammation Forum.
Date: September 23, 2026 Time: 1:00 PM – 1:25 PM ET Presenters: JD Finley, Chief Executive Officer; Mitchell Jones, President & Chief Medical Officer Format: Virtual
Get started
Create a free account to read the full story and Whiz Insights.